Browsing: Opportunities

The global GLP-1 market revenue surpassed USD 58.40 billion in 2025 and is predicted to attain around USD 212.73 billion by 2035, growing at a CAGR of 13.80%. The market is driven by the increasing prevalence of obesity and type 2 diabetes throughout the world, the effectiveness of GLP-1 agonists in terms of significant weight…